Taurine as a Potential Treatment for Cellular Aging and Chronic Inflammation in Long COVID: A Systematic Review and Meta-Analysis - Top-Institutions - MDSpire

Taurine as a Potential Treatment for Cellular Aging and Chronic Inflammation in Long COVID: A Systematic Review and Meta-Analysis

  • By

  • Kaiming Wang

  • Chen Hsiang Ma

  • Mobin Khoramjoo

  • Janice Y. Kung

  • Gavin Y. Oudit

  • March 10, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health (NIH) - National Institute on Aging (NIA)
    National Institutes of Health (NIH) - National Institute on Aging (NIA)

    Bethesda, MD

    Key Differentiators

    • Aging Research
    • Immunology
    • Infectious Diseases
    • Metabolomics

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Pulmonary Medicine
    • Neurology
    • Clinical Research

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Immunology
    • Geriatrics
    • Metabolomics
    • Clinical Trials

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Neurology
    • Aging Biology
    • Clinical Research

  • #5

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Metabolomics
    • Clinical Trials

Original Source(s)

Taurine as a Potential Treatment for Cellular Aging and Chronic Inflammation in Long COVID: A Systematic Review and Meta-Analysis

  • by Kaiming Wang, Chen Hsiang Ma, Mobin Khoramjoo, Janice Y. Kung, Gavin Y. Oudit

  • March 10, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Downstream Healthcare Use Associated with Primary Care In-Person and Telemedicine Visits in 2022

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection